Research

Nontuberculous mycobacterial infection in cystic fibrosis

Research in the Caverly Lab focuses on the airway microbiome in people with cystic fibrosis (CF) with nontuberculous mycobacterial (NTM) infection, including Mycobacterium abscessus and Mycobacterium avium complex. We use state-of-the-art technologies to define bacterial community composition and activity, and modeling to identify differences in infectious and inflammatory changes that are predictive of NTM infection and disease course. The goal of our research is to better inform decisions regarding NTM treatment and identify new approaches to reducing NTM infections in people with CF. 


Past and current support for Dr. Caverly includes: 

Cystic Fibrosis Foundation


National Institutes of Health/ NHLBI